Cardinal Health, Inc.

🇺🇸New York Stock Exchange
Back to all articles
Cardinal Health, Inc. stock analysis CAH overview
Bullish +60

Should Value Investors Buy Cardinal Health (CAH) Stock? - Yahoo Finance

📈 Cardinal Health (CAH) holds a Zacks Rank #2 (Buy) and an A-grade in the Value category according to the Style Scores system.

💰 CAH has a PEG ratio of 1.24, which is significantly lower than its industry average of 1.76, suggesting potential undervaluation relative to earnings growth.

💸 The stock's Price-to-Cash-Flow (P/CF) ratio stands at 15.27, compared to an industry average of 15.38, indicating it is competitively valued based on cash flow metrics.

🏥 For comparison, The Cooper Companies (COO) also carries a Zacks Rank #2 and an A-grade Value score in the medical supplies sector.

📊 COO's Forward P/E ratio of 15.59 is slightly below its industry average of 15.32, while its PEG ratio of 1.67 mirrors the market norm of 1.76.

📉 The Cooper Companies' P/B ratio of 1.62 is notably lower than the industry average of 4.56, highlighting a potentially undervalued asset base.

📈 Analysts suggest both CAH and COO represent strong value stocks currently given their impressive earnings outlooks and favorable valuation metrics.

💡 Value investors typically look for specific traits like high Zacks Rank grades combined with A-level Value scores to identify great companies.

🛑 While PEG ratios have fluctuated over the last 12 months, CAH's median of 1.49 remains below the industry average, supporting a buy rating.

⚠️ Investors are advised to consider both earnings estimates and individual strategies when deciding whether to purchase these value-oriented stocks.

Bullish Signals
  • Cardinal Health (CAH) holds a Zacks Rank #2 (Buy), indicating strong potential based on earnings estimates and revisions.
  • The stock also carries an 'A' grade in the Value category, positioning it as one of the strongest value stocks on the market today.
  • CAH has a PEG ratio of 1.24, which is significantly lower than its industry average of 1.76, suggesting attractive earnings growth relative to price.
  • The company's P/CF ratio stands at 15.27, which is more attractive than the industry average of 15.38 and signals strong cash flow.
  • Over the past 52 weeks, CAH's PEG ratio ranged from a low of 1.22 to a median of 1.49, demonstrating consistent value metrics compared to its sector.
Risk Factors
  • The article presents Cardinal Health (CAH) as a strong value stock with a 'Buy' Zacks Rank and an 'A' grade, lacking any mention of potential downside risks or competitive threats.
  • Analysts are suggesting that CAH is currently undervalued, which implies there is little to no negative sentiment regarding its current financial outlook within the text.
Full Analysis
Cardinal Health, Inc. (CAH) is highlighted as a potential value investment opportunity, currently holding a Zacks Rank of #2 (Buy) and an "A" grade in the Value category according to Zacks Investment Research's Style Scores system. The article notes that Cardinal Health trades with a Price-to-Earnings-and-Growth (PEG) ratio of 1.24, which is below its industry average of 1.76 and compares favorably to the stock's own recent range between 1.22 and 1.88. Additionally, the company exhibits a Price-to-Cash-Flow (P/CF) ratio of 15.27, slightly underpinning the sector average of 15.38, while maintaining a historical median P/CF around 15.12 over the past 52 weeks. The analysis suggests these metrics indicate the stock is undervalued relative to its growth outlook and industry peers. To provide further context for value-focused investors, the content draws a parallel to The Cooper Companies (COO), which shares similar attributes with a Zacks Rank #2 and an "A" Value score, though with slightly different valuation figures such as a Forward P/E of 15.59 compared to a lower industry average of 15.32. Both companies are presented as solid examples in the Medical-Dental Supplies sector for investors seeking undervalued positions based on fundamental metrics and earnings strength.